Chi Y.,Ji W.,Xiu B., et al. ERVMER34 sensitizes the response of HER2 positive breast cancer to neoadjuvant therapy [J].CANCER RESEARCH,2019,79(4).
APA:
Chi Y.,Ji W.,Xiu B.,Zhang Q.,&Wu J..(2019).ERVMER34 sensitizes the response of HER2 positive breast cancer to neoadjuvant therapy .CANCER RESEARCH,79(4).
MLA:
Chi Y., et al. "ERVMER34 sensitizes the response of HER2 positive breast cancer to neoadjuvant therapy" .CANCER RESEARCH 79,4(2019).